PEDMARK® (sodium thiosulfate injection)
| Full Name | PEDMARK® (sodium thiosulfate injection) |
| Drug | Pedmark |
| Manufacturer | Fennec Pharmaceuticals |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | Reduce the risk of ototoxicity associated with cisplatin in pediatric patients 1 month of age and older with localized, non-metastatic solid tumors |
| Disease | Ototoxicity associated with cisplatin |
| Therapeutic Area | Otolaryngology |
| Enrollment Form Link | Pedmark Enrollment Form |
| Phone Number | 800-385-8596 |
| Fax Number | 877-694-2545 |
| Product Website | pedmark.com |